Enwave corporation

Beleggen in aandelen beurs China Shanghai Composite, Toronto, etc.

Beleggen met ongekend lage tarieven?
Aandelen BE/NL €2+0,03% / VS €0,50+$0,004 p/st
Kernselectie: Geen kosten turbo's, ETF's en fondsen
DEGIRO: meer informatie / rekening openen


belegsel
Forum gebruiker
Forum gebruiker
Berichten: 124
Lid geworden op: 31 jul 2019 19:11
waarderingen: 107
Contacteer:

Re: Enwave corporation

Bericht door belegsel »

Mijn bericht van 18 november 2020 :

Misschien is de REV-technologie van Enwave ook geschikt voor het immuun bewaren van vaccins die nu aan extreem lage temperaturen moeten bewaard worden ?
In vorig bericht viel mij volgende zin op : "EnWave’s pharmaceutical technology allows for a rapid and controlled drying process for sensitive vaccines and biological compounds"

Heeft iemand er een zicht op of de REV-technologie een goed of misschien zelfs beter alternatief kan zijn voor bewaring van vaccins ?

Lees meer op: viewtopic.php?f=6&t=1905&start=900 voor meer informatie





Kareldeparel
Forum newbie
Forum newbie
Berichten: 8
Lid geworden op: 12 jan 2021 13:39
waarderingen: 3
Contacteer:

Re: Enwave corporation

Bericht door Kareldeparel »

Wat die farma toepassingen betreft ken ik niets. Het enige wat van belang is, is de snelheid waarmee die REV bepaalde componenten die farma gebruikt kan produceren en dat is het belangrijkste wat ik onthoud uit die mededeling.

Josken
Forum verkenner
Forum verkenner
Berichten: 93
Lid geworden op: 12 jul 2019 20:01
waarderingen: 59
Contacteer:

Re: Enwave corporation

Bericht door Josken »

Cannabis stocks blijven stijgen. As a reminder; US is een gi-gan-ti-sche markt voor Enwave.

The Cannabis ETF has gained 46% in the year-to-date, while the S&P 500 SPX, +1.39% has added 2%

link: https://www.marketwatch.com/story/canna ... 1612292635

-----------------------------------------------------------------------------------------------------------------------------------------
Cannabis stocks rally after Chuck Schumer leads drive for reforms that may end federal prohibition
Last Updated: Feb. 2, 2021 at 2:09 p.m. ET
First Published: Feb. 2, 2021 at 2:03 p.m. ET
By Ciara Linnane
13
Three Democratic senators are promising to present draft legislation within weeks

PHILIPPE LOPEZ/AGENCE FRANCE-PRESSE/GETTY IMAGES
Email icon
Facebook icon
Twitter icon
Linkedin icon
Flipboard icon
Print icon
Resize icon
Referenced Symbols
THCX
+9.22%
TLRY
+22.98%
APHA
+17.92%
APHA
+17.58%
ACB
+13.39%
ACB
+13.12%
CGC
+4.13%
WEED
+3.29%
CRON
+11.27%
CRON
+10.26%
SNDL
-14.05%
CURLF
+4.52%
CURA
+5.92%
CL
+9.36%
GTII
+6.22%
KERN
+14.35%
SPX
+1.39%
Cannabis stocks were mostly higher Tuesday after three Democratic senators led by Majority Leader Chuck Schumer said they would make reform legislation a key priority in the current Congress, bolstering hopes for an end to federal prohibition.

Schumer, along with Sens. Ron Wyden of Oregon and Cory Booker of New Jersey, said in a joint statement that they would introduce legislation in the coming weeks.

“The War on Drugs has been a war on people—particularly people of color. Ending the federal marijuana prohibition is necessary to right the wrongs of this failed war and end decades of harm inflicted on communities of color across the country. But that alone is not enough,” they said. “As states continue to legalize marijuana, we must also enact measures that will lift up people who were unfairly targeted in the War on Drugs.”

The statement comes after a strong rally in the sector, driven by optimism that the new administration of President Joe Biden would pursue an agenda of reforming the U.S.’s strict cannabis laws, which continue to classify the substance as a Schedule I drug, alongside heroin.

That classification has hampered the development of the sector, which is confined to those states that have legalized cannabis for medical or recreational use and kept companies locked out of the federally insured banking system.

Jefferies analyst Owen Bennett said that while Schumer has made encouraging noises in the past about overhauling the laws, the latest move is the first time lawmakers have made a formal commitment. The past roadblock — Republican Sen. Mitch McConnell of Kentucky — has been removed with the Democratic takeover of the Senate, he said.

“With cannabis legalization having overwhelming public bipartisan support, many Republican states already legalizing cannabis, potential tax revenue, and Schumer last week saying the newly planned bill already has support from ‘some Republicans,’ we think (there’s) a strong chance of (it) advancing to Biden’s desk.

See also: New York is finally expected to legalize cannabis in 2021 as Gov. Cuomo goes all in

“Importantly, while Biden has previously been against full legalization, he has said he supports allowing the states to decide, which looks to be the form that any newly proposed legislation would take,” Bennett wrote in a note to clients.

The analyst noted that Vice President Kamala Harris supported last year’s MORE Act (Marijuana Opportunity, Reinvestment, and Expungement Act), a bipartisan bill that was approved in the House but died in the Senate.

Master Your Money | Wed 1 p.m. ET, Feb. 3-17
MarketWatch and Barron’s editors will convene top experts to discuss what is happening in the world, and how it may affect your personal finances. This series will help beginner investors understand and navigate the current landscape. Find out what has worked well, what to avoid, and ask questions.
SIGN UP NOW
MarketWatch on Multiple devices
Don’t miss: SEC takes enforcement action against IGC for claims made about cannabis-based treatment for Alzheimer’s symptoms

That would suggest that any pending legislation will include safe-harbor language for banking, enable companies to uplist to established U.S. exchanges and crack open the capital markets to institutional funding, all factors that current legislation has prevented.

“With any legislation likely to remove these barriers, expect a huge inflow of institutional money which is likely to send US sector valuations materially higher,” Jefferies’ Bennett wrote.

Canaccord analyst Bobby Burleson said he expects the MORE Act and the SAFE Banking Act (Secure and Fair Enforcement Act) to form the basis of new federal leglisation. The SAFE Act was also passed by the House more than 16 months ago, but failed to gain traction in the then Republican -led Senate.

“With the Democrats now able to better control the flow of legislation through the Senate, we believe the prospects of cannabis operators being able to access more traditional forms of capital could help decrease the overall cost of capital and increase the operating efficiency of the sector as whole,” Burleson wrote in a note to clients.

Against that background, the Cannabis ETF THCX, +9.22% was up 6%, with 29 of its 30 component stocks gaining ground.

Among individual stocks, Tilray Inc. TLRY, +22.98%, which is merging with Aphria Inc. APHA, +17.92% APHA, +17.58%, was up 16%, while Aphria was up 11%.

Aurora Cannabis Inc. ACB, +13.39% ACB, +13.12%. , one of the most widely held cannabis stocks thanks to its popularity with Robinhood traders, was up 10%. Canopy Growth Corp. CGC, +4.13% WEED, +3.29% was up 6% and Cronos Group Inc. CRON, +11.27% CRON, +10.26% was up 12%.

Read: As pot stocks boom on hopes for U.S. legalization, Canadian cannabis companies struggle for growth

Sundial Holdings Inc. SNDL, -14.05%, a penny stock that once boasted a $1 billion valuation, was down 11%, after unveiling another dilutive capital raise.

The company has now fully used up its shelf registration, meaning it will have to file a new one to issue any new securities.

Among U.S. companies, Curaleaf Holdings Inc. CURLF, +4.52% CURA, +5.92% was up 4%, Cresco Labs Inc. CL, +9.36% CL, +9.36% was up 6% and Green Thumb Industries Inc. GTII, +6.22% was up 4%. Akerna Corp. KERN, +14.35%, which makes software for the cannabis industry, was up 5%.

The Cannabis ETF has gained 46% in the year-to-date, while the S&P 500 SPX, +1.39% has added 2%.
ancaoli liked last!

Josken
Forum verkenner
Forum verkenner
Berichten: 93
Lid geworden op: 12 jul 2019 20:01
waarderingen: 59
Contacteer:

Re: Enwave corporation

Bericht door Josken »

Alle info combined, ziet Beurstips de weerstand rond 1.46 CAD nog binnen de komende weken sneuvelen!
All credits go to BT/Bart Goemaere, BT 3 feb 2021.

marcator
Forum actieveling
Forum actieveling
Berichten: 609
Lid geworden op: 17 okt 2014 16:37
waarderingen: 445
Contacteer:

Re: Enwave corporation

Bericht door marcator »

janf schreef:
26 jan 2021 17:02
Ik hoop op wat institutionele beleggers die hier ook iets in zien en in groot volume opkopen.
Tijdens een pandemie en wereldwijde vaccinatiecampagne is dat toch iets dat de aandacht trekt.
In zijn recente interview bij " SSN Network's Virtual Events " , wat terug te vinden is op enwave.net , geeft CEO Brent Charleton hier en daar wel wat interessant info vrij :

- ongeveer 60pct van de aandelen zit bij "high network en institutionele" beleggers.
- bovendien zit ong. 30pct van de aandelen bij beleggers in B, NL en D wellicht dankzij Beurstips en partner Smallcaps.us , SmallCap-Investor.de en Commodity-TV met de immer enthousiaste Jochen Staiger, diverse interviews van de laatste 2 analysten zijn terug te vinden op youtube.
(note : enkele jaren geleden had Bank Degroof ook een positie van 500.000 aandelen, maar die heb ik niet meer teruggevonden in hun laatste jaarverslag)

- hij verwacht binnenkort extra machines te verkopen bij enkele bestaande klanten die stilaan tegen hun max REV capacity draaien , dus "repeat purchase orders" komen er aan
- hij hoopt op nieuwe deals dit jaar met "formidable" klanten in de "household sector, uit de 'fortune500' lijst en verwacht dat snacks bedrijven ook meer risico willen nemen met nieuwe product launches op basis van ENW technologie
- de REV installatie in Peru is afgewerkt en gaat dus bijdragen aan de royalty inkomsten
- de komende 2 maanden worden nieuwe retail deals verwacht voor verdere uitrol MoonCheese verkoopsnetwerk , ook online Amazon verkopen trekken aan
- Revworks productiefaciliteiten starten binnenkort op (o.a. 60KW machine ex Tilray wordt hiervoor herbruikt startup maart21), en de order pipeline loopt zeer goed, versnelt speed-to-market lancering voor nieuwe, innovatieve producten
- Cannabis sector blijft veelbelovende markt , met 3 verschillende droogprogramma's kunnen ze de diverse toepassingen in de sector bedienen

In de wrap up laat Brent (op minuut 21 van de presentatie) nog weten dat de 1Q cijfers (Oct-Dec20) "heel goed" zijn , ze komen "aan de goede kant" uit de krisis en ze staan voor een "ongelofelijk mooie (incredibly bright) " toekomst in de komende 2 jaar

Kortom , de kans is groot dat de volgende groeispurt begint bij de Q-resultaten, op 19Februari, da's niet zo veraf meer...
maartenverhoeve liked last!
Buy low, Sell high.

Kareldeparel
Forum newbie
Forum newbie
Berichten: 8
Lid geworden op: 12 jan 2021 13:39
waarderingen: 3
Contacteer:

Re: Enwave corporation

Bericht door Kareldeparel »

Mooi, ik zit hier op 200.000 stuks....eindelijk wat goed nieuws na het Nyrstar debacle. Nog twee jaar geduld.
marcator liked last!

kopke1
Forum actieveling
Forum actieveling
Berichten: 310
Lid geworden op: 15 nov 2013 21:36
waarderingen: 153
Contacteer:

Re: Enwave corporation

Bericht door kopke1 »

EnWave Signs Equipment Purchase Agreement with Nanuva Ingredients to Expand Commercial Manufacturing Capacity in Chile



Vancouver, B.C., February 9th, 2021

EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave” or, the "Company") announced today that it has signed a third Equipment Purchase Agreement (“EPA”) with Natural Nutrition SpA d.b.a. Nanuva Ingredients (“Nanuva”) for Nanuva’s operations in Chile. This EPA calls for the construction and commissioning of an additional two 10kW Radiant Energy Vacuum (“REV™”) dehydration machines. Nanuva currently uses REV™ technology to produce high-quality fruit snacks, ingredients and powders that are sold on a business-to-business basis internationally. The additional two 10kW REV™ machines will significantly increase Nanuva’s commercial manufacturing capacity, allowing them to meet their growing market demand.

Nanuva first entered a royalty-bearing commercial license to use EnWave’s patented dehydration technology to process premium South American fruits in 2014. Over the duration of this partnership, Nanuva has steadily increased its REV™ manufacturing capacity. Nanuva anticipates additional growth in the coming years and expects to expand upon the five 10kW machines they plan to have in operation by mid 2021.

Nanuva produces a broad portfolio of premium fruit products that includes apple, blackberry, blueberry, and pineapple, as well as superfoods such as maquiberry, and rosehip. Nanuva has experienced growing product demand for export into the U.S. market and gained new contract manufacturing opportunities, resulting in this need for additional REV™ capacity to satisfy demand.

In recognition of increasing demand for small scale REV™ machines, EnWave had previously commenced production of a number of 10kW units. Two of these units will now be dedicated and completed for the Nanuva EPA with anticipated delivery and commissioning in late Spring 2021.

EnWave’s patented vacuum-microwave drying technology is a proven method for producing premium dried fruit products with optimal nutritional retention, enhanced textures and vibrant colours. To date, EnWave has signed 14 royalty-bearing commercial licenses for the processing of premium agricultural products in 12 countries around the world.

In total, EnWave now has 41 active royalty-bearing licenses in place with food, cannabis and pharmaceutical companies for the use of REV™ technology.


About Nanuva Ingredients
Natural Nutrition SpA (d.b.a. “Nanuva Ingredients”) aims to deliver 100% natural products with no additives that are healthy and safe for the global ingredients industry, while minimizing the loss of the nutritional value of the fresh ingredients. Nanuva Ingredients is strategically located near the fruit growing center in the Bíobío Region, in the South of Chile.

Nanuva Ingredients is at the forefront of agro-industrial innovation, using REV™ technology and sourcing the most premium raw materials to create healthy and sustainable fruit powders, ingredients and fragments for both consumers and industrial clientele. Nanuva Ingredients is recognized by its customers for its premium products that have market-leading flavours, colours shapes and nutritional value like those of fresh fruit. Nanuva Ingredient’s products are used as healthy ingredients in the snack food, functional food, nutraceutical and cosmetics industry. For more information on Nanuva Ingredients, please visit www.nanuva.cl.

Safe Harbour for Forward-Looking Information Statements: This press release may contain forward-looking information based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures, and the expected synergies following the closing are forward-looking statements. All third party claims referred to in this release are not guaranteed to be accurate. All third party references to market information in this release are not guaranteed to be accurate as the Company did not conduct the original primary research. These statements are not a guarantee of future performance and involve a number of risks, uncertainties and assumptions. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
marcator liked last!

Gebruikersavatar
maartenverhoeve
Forum veteraan
Forum veteraan
Berichten: 1507
Lid geworden op: 02 jan 2012 21:42
waarderingen: 343
Contacteer:

Re: Enwave corporation

Bericht door maartenverhoeve »

Hoog volume door de weerstand van 1,46 cad. Op naar schitterende jaarcijfers, hopelijk in groene inkt.
HoubyTelli liked last!
In port; Enwave, Ageas, Western Cop, Retail estate, RDS, kbca, roularta, Tessenderlo.,oci, Forfarmers, American airlines en veel arrowhead pharma....

Kingair
Forum verkenner
Forum verkenner
Berichten: 46
Lid geworden op: 13 aug 2014 16:49
waarderingen: 17
Contacteer:

Re: Enwave corporation

Bericht door Kingair »

U.S. Army has signed a purchase contract with EnWave to supply a 10kW REV dehydration machine. This machine will be used by a third-party contract manufacturer to produce Close Combat Assault Rations for field testing
U kunt zich hier registreren waarna u de bijlage kunt bekijken.
Josken liked last!

Josken
Forum verkenner
Forum verkenner
Berichten: 93
Lid geworden op: 12 jul 2019 20:01
waarderingen: 59
Contacteer:

Re: Enwave corporation

Bericht door Josken »

De puzzelstukken vallen in elkaar!
Eindelijk rugwind op al hun verticals; food, pharma, cannabis & hemp, backed up door grote gereputeerde namen.
maartenverhoeve liked last!


Deelnemen aan het forum + meer functies?

Deel kennis en vragen met duizenden beleggers,
minder advertenties, ideaal voor smartphone, betere
gebruikservaring en gratis abonneren op favoriete
onderwerpen. Registreer binnen 1 minuut!



Plaats reactie